Skip to main content
logo
Apellis Pharmaceuticals, Inc. (APLS)
May 14, 2026 - APLS was delisted (reason: acquired by BIIB)
41.03
-0.03 (-0.07%)
Inactive · Last trade price on May 13, 2026

Apellis Pharmaceuticals Revenue

Apellis Pharmaceuticals had revenue of $268.30M in the quarter ending March 31, 2026, with 60.85% growth. This brings the company's revenue in the last twelve months to $1.11B, up 42.46% year-over-year. In the year 2025, Apellis Pharmaceuticals had annual revenue of $1.00B with 28.46% growth.

Revenue (ttm)
$1.11B
Revenue Growth
+42.46%
P/S Ratio
4.75
Revenue / Employee
$1,495,643
Employees
739
Market Cap
5.25B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.00B222.41M28.46%
Dec 31, 2024781.37M384.78M97.02%
Dec 31, 2023396.59M321.17M425.83%
Dec 31, 202275.42M8.86M13.31%
Dec 31, 202166.56M-184.08M-73.44%
Dec 31, 2020250.65M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

APLS News

More News